Edwards Lifesciences (NYSE:EW) traded higher on Thursday after Stifel upgraded the heart device maker to Buy from Hold, citing a turnaround in its position in the market for transcatheter aortic valve ...
When to visit a Cardiac Surgeon? Understanding when to consult a cardiac surgeon is crucial for managing heart ailments effectively. Persistent chest pain, severe shortness of breath, unexplained ...
Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also ...